Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v4-EN | Version v2-FR | |
|---|---|---|
| Language | English | French |
| Date Updated | 2020-11-13 | 2020-10-27 |
| Drug Identification Number | 02403277 | 02403277 |
| Brand name | JENTADUETO | JENTADUETO |
| Common or Proper name | JENTADUETO 2.5/1000MG TABS, 6X10 | JENTADUETO 2.5/1000MG TABS, 6X10 |
| Company Name | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | BOEHRINGER INGELHEIM (CANADA) LTD LTEE |
| Ingredients | LINAGLIPTIN METFORMIN HYDROCHLORIDE | LINAGLIPTIN METFORMIN HYDROCHLORIDE |
| Strength(s) | 2.5MG 1000MG | 2.5MG 1000MG |
| Dosage form(s) | TABLET | TABLET |
| Route of administration | ORAL ORAL | ORAL ORAL |
| Packaging size | BLISTER PACK 6X10 | BLISTER PACK 6X10 |
| ATC code | A10BD | A10BD |
| ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
| Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
| Anticipated start date | 2020-10-27 | 2020-10-27 |
| Actual start date | 2020-10-27 | 2020-10-27 |
| Estimated end date | 2020-11-18 | 2020-11-09 |
| Actual end date | ||
| Shortage status | Actual shortage | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | ||
| Health Canada comments |